C21H32N8O5 — CID 171321912
(4aR,6S,8aS)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-6-morpholin-4-yl-N-(1H-1,2,4-triazol-5-ylmethyl)-1,3,4,4a,5,6,7,8-octahydroisoquinoline-8a-carboxamide;formic acid (PubChem CID 171321912) has the molecular formula C21H32N8O5 and a molecular weight of 476.54 g/mol. Its IUPAC name is (4aR,6S,8aS)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-6-morpholin-4-yl-N-(1H-1,2,4-triazol-5-ylmethyl)-1,3,4,4a,5,6,7,8-octahydroisoquinoline-8a-carboxamide;formic acid.
| Compound Name | (4aR,6S,8aS)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-6-morpholin-4-yl-N-(1H-1,2,4-triazol-5-ylmethyl)-1,3,4,4a,5,6,7,8-octahydroisoquinoline-8a-carboxamide;formic acid |
|---|---|
| PubChem CID | 171321912 |
| Molecular Formula | C21H32N8O5 |
| Molecular Weight | 476.54 g/mol |
| Exact Mass | 476.25 |
| IUPAC Name | (4aR,6S,8aS)-2-(5-methyl-1,2,4-oxadiazol-3-yl)-6-morpholin-4-yl-N-(1H-1,2,4-triazol-5-ylmethyl)-1,3,4,4a,5,6,7,8-octahydroisoquinoline-8a-carboxamide;formic acid |
| SMILES | Cc1nc(N2CC[C@@H]3C[C@@H](N4CCOCC4)CC[C@@]3(C(=O)NCc3ncn[nH]3)C2)no1.O=CO |
| InChI | InChI=1S/C20H30N8O3.CH2O2/c1-14-24-19(26-31-14)28-5-3-15-10-16(27-6-8-30-9-7-27)2-4-20(15,12-28)18(29)21-11-17-22-13-23-25-17;2-1-3/h13,15-16H,2-12H2,1H3,(H,21,29)(H,22,23,25);1H,(H,2,3)/t15-,16+,20-;/m1./s1 |
| InChIKey | USCNABDHKZCOHK-PDDHCYGISA-N |
| XLogP | 0.21 |
| TPSA | 162.60 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 476.54 |
| LogP ≤ 5 | 0.21 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|